Adlai Nortye Ltd ADRANL
Price$16.00Intrinsic value$3.7177% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $5MTTM through 31 Dec 2024
Net Income -$51.9MTTM through 31 Dec 2024
Free Cash Flow -$52MTTM through 31 Dec 2024

Margins

Current
Operating Margin-714.0%
Net Margin-1,037.4%

Returns

-203.5%ROE
-72.8%ROA

Balance Sheet Health

Debt / Equity1.03x
Current Ratio1.41x
Net Debt-$34.6Mnet cash position
Cash & Equivalents$60.9M

Quality Metrics

Piotroski F-Score2 / 9
FCF Margin-1,039.8%

Multi-Year Trend

Revenue
'21'23
FY2023: $5M
Diluted EPS
'21'22'23'24
FY2024: $-0.54

Dividend

No dividend

Capital Allocation

Capex Intensity3.4%

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.